BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• YITU Showcases Smart City Solutions at UNIDO Event to Enhance Global Urban Livability

  Over 188 cities from 88 countries attended the event.

  October 11, 2018

   · 

  3 min read
• Job Trends

  Global RIM Survey Ranks AMPLEXOR as Leader for Innovation and Delivery, Outstanding Customer Satisfaction

  AMPLEXOR’s prominence in the ‘innovation index’ reflected in customer feedback as Life Sciences firms look for more than just compliance

  October 11, 2018

   · 

  4 min read
• BioMidwest

  Heart Center Dresden to Be First Commercial Clinical Site for Imricor

  Imricor achieves commercial milestone with first customer contract

  October 11, 2018

   · 

  3 min read
• Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City Today, 11 October, 2018

  Symposium faculty to include Dmitriy Zamarin, MD, PhD, and Alexander N. Shoushtari, MD, medical oncologists from Memorial Sloan Kettering Cancer Center

  October 11, 2018

   · 

  2 min read
• Novaliq Raises New Capital to Accelerate the Commercialization of its Lead Products for Dry Eye Disease

  Focus on clinical development and to prepare commercialization of CyclASol® and NOV03

  October 11, 2018

   · 

  3 min read
• Business

  Carrick Therapeutics In-Licenses Targeted Ovarian Cancer Treatment From BTG and Appoints George Golumbeski as Chairman

  Exclusive worldwide licence deal adding to Carrick’s rapid pipeline expansion

  October 11, 2018

   · 

  7 min read
• Deals

  Generational Equity Advises Louis Wohl & Sons in Sale to BJ Beltram

  Generational Equit is pleased to announce the sale of its client, Louis Wohl & Sons Group, to BJ Beltram Inc.

  October 11, 2018

   · 

  2 min read
• Business

  Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation to Develop and Commercialize Oncolytic Virotherapies

  Themis to expand measles vector immunomodulation portfolio into oncology indications

  October 11, 2018

   · 

  4 min read
• TD Advances Innovation in Canadian Healthcare

  Commits $2.5 million to support University of Toronto’s Creative Destruction Lab Health Stream

  October 11, 2018

   · 

  5 min read
• Business

  MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies

  MEI Pharma, Inc. and BeiGene, Ltd. today announced a clinical collaboration to evaluate the safety and efficacy of MEI’s ME-401

  October 11, 2018

   · 

  7 min read